Efficacy of P2Y12 receptor antagonists in patients with atrial fibrillation according to the CHA2DS2VASc score

Martina Ondrakova; Jiri Knot; Jaroslav Ulman; Marek Maly; Zuzana Motovska

doi:10.1016/j.ijcard.2016.01.039

Efficacy of P2Y12 receptor antagonists in patients with atrial fibrillation according to the CHA2DS2VASc score

Int J Cardiol. 2016 Mar 15:207:84-6. doi: 10.1016/j.ijcard.2016.01.039. Epub 2016 Jan 6.

Authors

Martina Ondrakova¹, Jiri Knot¹, Jaroslav Ulman¹, Marek Maly², Zuzana Motovska³

Affiliations

¹ University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
² The National Institute of Public Health, Prague, Czech Republic.
³ University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: motovska.zuzana@gmail.com.

PMID: 26797336
DOI: 10.1016/j.ijcard.2016.01.039

No abstract available

Keywords: Atrial fibrillation; CHA(2)DS(2)VASc score; High on treatment platelet reactivity; P2Y(12) receptor antagonists; Percutaneous coronary intervention.

Publication types

Clinical Trial
Letter

MeSH terms

Aged
Aged, 80 and over
Atrial Fibrillation / diagnosis*
Atrial Fibrillation / drug therapy*
Female
Humans
Male
Middle Aged
Percutaneous Coronary Intervention / trends
Prospective Studies
Purinergic P2Y Receptor Antagonists / therapeutic use*
Severity of Illness Index*
Treatment Outcome

Substances

Purinergic P2Y Receptor Antagonists